Opendata, web and dolomites

Spectra

Spectra- A novel diagnostic device to improve retinal imaging

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Spectra project word cloud

Explore the words cloud of the Spectra project. It provides you a very rough idea of what is the project "Spectra" about.

diabetics    photograph    models    expensive    exist    benefitted    sickness    retinopathies    patients    age    retinopathy    damage    diseases    eminently    adaptable    retineye    treatable    macular    uk    social    dr    reducing    english    rarer    greatest    analytical    security    degeneration    providers    ocular    certified    lacking    sight    diagnostic    detects    missed    time    risk    throughput    caring    severe    staff    biomarkers    diabetes    records    unaware    street    easier    patient    preventable    attendance    integration    suspected    50    earlier    countries    markets    causes    economic    medical    lower    glaucoma    monitor    optometrists    burdens    until    deployments    cataracts    stages    diabetic    clinic    software    portable    portability    seamless    screening    standalone    spectra    footfall    complemented    detect    qualified    teleopthalmology    reported    pressure    irreversible    nhs    tremendous    desp    enabled    retinal    intelligence    fundus    packages    tests    date    urgent    eye    benefits    highlights    health    referrals    blindness    national    46   

Project "Spectra" data sheet

The following table provides information about the project.

Coordinator
HEALTH INTELLIGENCE LTD 

Organization address
address: MOSTON ROAD SAXON HOUSE
city: SANDBACH
postcode: CW11 3HL
website: www.health-intelligence.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://health-intelligence.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HEALTH INTELLIGENCE LTD UK (SANDBACH) coordinator 50˙000.00

Map

 Project objective

Health Intelligence provide medical software as diagnostic medical devices. We have developed retinal (fundus) photograph analytical software - Spectra, complemented by the lower cost, standalone and portable Spectra Retineye. Spectra is one of only three software packages certified by the English National Diabetic Retinopathy (DR) Screening Programme. It has benefitted screening providers by seamless integration with patient records and ability to monitor over time. Providers reported improved throughput and attendance. Spectra highlights much more than just DR. In deployments to date, over 50% of urgent eye clinic referrals are for suspected non-diabetic retinopathies. Thus, Spectra detects reliable biomarkers for many conditions. The greatest causes of blindness (after cataracts) are glaucoma, age-related macular degeneration and DR. Spectra can detect early and treatable stages of these diseases, in particular low-pressure glaucoma missed by ocular pressure tests. New markets also exist for diabetic eye screening programmes (DESP) in countries lacking the resources of the UK NHS. Teleopthalmology (enabled by Spectra Retineye) could deliver these. Both Spectra and Spectra Retineye can deliver economic benefits: • Reducing need for expensive equipment and highly-qualified staff • Portability • Increased footfall in high-street optometrists from eye screening patients • Easier and lower cost of screening to patients • Reduced social security costs due to sight loss Spectra will deliver tremendous social benefits. Preventable, irreversible sight damage will become rarer, reducing sickness and caring burdens. Spectra Retineye, which is eminently adaptable to teleopthalmology will allow more delivery models. These will detect more problems earlier, including the 46% of diabetics who are unaware they have diabetes and thus risk severe sight loss and other health problems until they are identified.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SPECTRA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SPECTRA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More